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ABSTRACT   
Time domain multi-wavelength (635 to 1060 nm) optical mammography was performed on 82 subjects with breast lesions 
(45 malignant and 38 benign lesions). A perturbative approach based on the high-order calculation of the pathlength of 
photons inside the lesion was applied to estimate differences between lesion and average healthy breast tissue in terms of: 
i) absorption properties, and ii) concentration of the major tissue constituents (oxy- and deoxy-hemoglobin, water, lipid 
and collagen). The absorption difference ∆µa between lesion and healthy tissue is significantly different for malignant vs. 
benign lesions at all wavelengths. Logistic regression fitted to the absorption data identifies 975 nm as the key wavelength 
to discriminate malignant from benign lesions. When the difference in tissue composition between lesion and healthy tissue 
is considered, malignant lesions are characterized by significantly higher collagen content than benign lesions. Also the 
best model for the discrimination of malignant lesions obtained applying regression logistic to tissue composition is based 
only on collagen.  
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1. INTRODUCTION  
One in 8 women in the U.S. and 1 in 10 in most EU countries will develop breast cancer in their lifetime. Breast screening 
primarily relies on x-ray mammography, which has reduced sensitivity in patients with dense glandular breasts, including 
young women and may have limited specificity, leading to unnecessary treatment.  
Optical mammography can operate at multiple wavelengths, combining imaging and spectroscopic information for lesion 
detection and characterization. In addition to its non-invasive nature, optical mammography has the capability to 
investigate dense breasts, typical of young women. The optical estimate of breast tissue composition might thus allow the 
discrimination between malignant and benign lesions. Most studies performed so far on the optical characterization of 
breast lesions have focused on the estimate of blood parameters, reporting increased blood content in breast cancers as 
compared to the surrounding healthy tissue. Only few studies quantified also of water and lipids, reporting a reduction in 
lipid content and an increase in water and blood compared to normal breast tissue.  
Collagen is involved in the onset and progression of breast cancer and might prove useful for the detection and 
characterization of breast lesions. In the present study, we investigate the differences in absorption properties of malignant 
and benign lesions as compared to healthy tissue at 7 wavelengths in the range 635 to 1060 nm, and estimate tissue 
composition in malignant and benign breast lesions, including also collagen among the tissue constituents that are 
considered.  
2. MATERIALS AND METHODS 
2.1. Instrument set-up 
The instrument was designed to collect projection images in compressed breast geometry. Time-resolved transmittance 
measurements were performed at seven wavelengths (635, 685, 785, 905, 930, 975, 1060 nm) using picosecond pulsed 
diode lasers and two PC-boards for time-correlated single photon counting. The compressed breast was raster-scanned 
continuously, moving the illumination fiber and collecting bundle in tandem and recording data every millimeter. Optical 
images were acquired from both breasts in cranio-caudal and medio-lateral oblique (45°) views.  
2.2. Patient study 
The Institutional Review Board at the European Institute of Oncology approved the clinical study. Written informed 
consent was obtained from all the participants. The study had twofold aim: i) the non-invasive assessment of breast density 
by optical means (not considered here), and ii) the optical characterization of malignant and benign lesions. A retrospective 
study was performed on 218 subjects, and optical images were analyzed comparing them to x-ray mammograms acquired 
in the same views. 82 subjects were further considered for the present analysis: 45 had malignant breast lesions (including 
33 ductal invasive carcinomas) and 38 benign breast lesions (including 14 fibroadenomas).  
2.3. Data analysis 
Information on tissue composition and structure is obtained directly from time-resolved curves measured at 7 wavelengths. 
A spectrally constrained global fitting procedure, based on an analytical solution of the diffusion approximation (with the 
extrapolated boundary condition) for an infinite homogeneous slab, is applied. Free parameters of the fit are the 
concentrations of oxy- and deoxy-hemoglobin (HbO2 and Hb, respectively), water, lipids, and collagen concentrations, 
together with the scattering amplitude a and power b.  
The Beer law is then used to estimate the absorption coefficient at each wavelength from the concentrations of the main 
tissue constituents. By the knowledge of the parameters a and b, the reduced scattering coefficient is modeled and obtained 
through a simple approximation to Mie theory: µ’s = a(λ/λo)–b, where we set λo = 600 nm; in this way a is the interpolated 
scattering coefficient µ’s(λo). 
In order to optically characterize breast lesions, they were described as localized absorption perturbations, embedded in an 
otherwise homogeneous diffusive medium, and a perturbation model based on the high-order calculation of the pathlength 
of photons inside the lesion was applied.[1] The perturbation model relies on the a priori knowledge of the volume and 
location of the inhomogeneity, which was always assumed as spherical, since only one dimension (i.e., the maximum 
diameter) was known, and located halfway between the injection and detection points, as no information on the depth was 
available.  
The statistical significance of the difference between two groups (e.g., absorption properties of malignant vs benign lesions 
at 635 nm) was assessed using the Mann-Whitney test at alpha = 0.05. Significance was considered when p < 0.05. The 
best regression logistic models to identify malignancy based on absorption properties or tissue composition were chosen 
via a stepwise variables selection minimizing the AIC (Akaike Information Criterion). 
3. RESULTS AND DISCUSSION 
The perturbative approach applied in the present study allows the estimate of absorption differences ∆µa between diseased 
tissue (either a malignant or a benign breast lesion) and average tissue in the same breast. On average malignant lesions 
are characterized by higher ∆µa values than benign lesions. The difference is particularly marked at the shortest 
wavelengths and at 975 nm (Table 1 and Fig. 1). The estimated ∆µa values are spread over a broad range. In this initial 
stage, very different lesion types were included in each of the two groups. This certainly affects the results and further 
analysis is needed to determine if specific lesion types have characteristic properties. However, there is a significant ∆µa 
difference (p < 0.05) between the two general categories of malignant and benign lesions at each of the 7 wavelengths. 
Table 1. Median of the absorption differences ∆µa for malignant and benign breast lesions  
Lesion type 635 nm 685 nm 785 nm 905 nm 930 nm 975 nm 1060 nm 
Malignant 0.093 0.061 0.060 0.057 0.035 0.108 0.042 




Figure 1. ∆µa at 7 wavelengths (635-1060 nm) for malignant (red) a benign (green) breast lesions. 
The best logistic regression model obtained fitting to the absorption differences estimated at all wavelengths turned out to 
depend only on ∆µa at 975 nm. It allows the discrimination of malignant lesions with sensitivity of 0.89, but very low 
specificity (0.28).  
The differences ∆Ci in concentration of tissue constituents between breast lesions and healthy tissue were estimated relying 
on the Beer law (Fig. 2 and table 2). Only the difference in collagen content allows on average to distinguish malignant 
from benign lesions, with the former being characterized by significantly higher (p = 0.0018) collagen content than benign 
lesions with respect to healthy tissue.  
Table 2. Median of the concentration differences ∆Ci for malignant and benign breast lesions  
 
  
Figure 2. ∆Ci for malignant (red) a benign (green) breast lesions. 
When concentration differences are considered, the best logistic regression model depends only on collagen content. It 
allowed the discrimination of malignant lesions with sensitivity of 0.88, but the specificity was still low (0.32).  
As mentioned previously, the two categories of malignant and benign lesions considered here include different types of 
lesions that may have very different composition and absorption properties. Moreover, different scattering properties can 
be envisaged (e.g., between liquid lesions, such as cysts, and solid ones, such as fibroadenomas). Taking them into account 
might improve the model. More in general, further analysis is being performed to achieve a better discrimination between 
malignant and benign lesions. 
REFERENCES 
[1] Sassaroli, A., Martelli, F. and Fantini, S., "Perturbation theory for the diffusion equation by use of the moments 
of the generalized temporal point-spread function. I. Theory," J. Opt. Soc. Am. A Opt. Image Sci. Vis. 23, 2105-
























































































Lesion type ∆Hb (µM) ∆HbO2 (µM) ∆Lipids (%) ∆Water (%) ∆Collagen (%) 
Malignant 5.15 5.76 -15.57 11.12 58.25 
Benign 3.57 4.56 -10.95 9.95 31.75 
